ADVAIR DISKUS
Sponsors
GlaxoSmithKline, Valley Medical Research, Teva Branded Pharmaceutical Products R&D, Inc., Johns Hopkins University, Wake Forest University Health Sciences
Conditions
AsthmaBioequivalenceCOPDCOPD ExacerbationChronic Obstructive Pulmonary DiseaseDepressionPersistent Asthma
Phase 1
Phase 2
Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects
CompletedNCT01772368
Start: 2013-01-31End: 2013-06-30Updated: 2017-06-12
Environmental Control as Add-on Therapy in Childhood Asthma
CompletedNCT02251379
Start: 2014-10-01End: 2018-11-30Updated: 2019-11-20
Phase 3
Phase 4
Study Of Allergic Rhinitis In Patients Who Also Have Asthma
CompletedNCT00296491
Start: 2005-09-30End: 2007-10-31Updated: 2016-12-16
A Study In Pediatric Subjects With Asthma Using ADVAIR HFA, ADVAIR HFA With Spacer, And ADVAIR DISKUS
CompletedNCT00400608
Start: 2006-10-31End: 2007-02-28Updated: 2016-10-28
The Effect on Depressive Symptoms in ECF Residents With COPD
CompletedNCT00974246
Start: 2009-10-31End: 2011-07-31Updated: 2016-12-28
Nebulizer Versus Dry Powdered Inhalers for Chronic Obstructive Pulmonary Disease (COPD)
TerminatedNCT03219866
Start: 2017-10-03End: 2020-04-01Updated: 2021-06-22